Prostate cancer is one of those diseases that hides in plain sight. It can develop slowly, show no symptoms, and quietly progress until it’s too late to treat easily. Yet it’s also one of the most survivable cancers—if it’s caught early.
The difference between those two paths often comes down to a single line on a lab report—and whether someone decided to order it.
What the Prostate Does—and Why It Matters
The prostate is a small gland about the size of a walnut, sitting just below the bladder in men. Its main job is to produce seminal fluid, which nourishes and protects sperm. Over time—especially after age 50—it tends to enlarge. That’s often benign (known as benign prostatic hyperplasia, or BPH), but sometimes the cells inside begin dividing abnormally.
Prostate cancer is the most common non-skin cancer among men in the U.S. The American Cancer Society estimates that roughly one in eight men will be diagnosed during their lifetime. The good news is that when found early and confined to the prostate, the five-year survival rate approaches 100%. Once it spreads beyond the gland, however, survival drops sharply.
Screening: What the Guidelines Say
The main screening tool for prostate cancer is the PSA (prostate-specific antigen) test, a blood test that measures a protein produced by both healthy and cancerous prostate cells.
Current U.S. Preventive Services Task Force (USPSTF) and American Medical Association (AMA) guidelines recommend that men between ages 50 and 69 discuss PSA screening with their doctor. For higher-risk groups—such as African American men or those with a family history of prostate cancer—the discussion should start around age 45.
The standard recommendation is to test once every two to three years, depending on results and risk factors. The digital rectal exam (DRE)—in which a doctor feels the prostate for irregularities—can still play a supporting role, though it’s used less frequently today as a first-line test.
The Accuracy Problem
Both the PSA and DRE have their limits.
The PSA test, while useful, is far from perfect. Studies show that at a cutoff of 4.0 ng/mL, its sensitivity (ability to correctly detect cancer) ranges from 21% to 51%, while its specificity (ability to correctly identify men without cancer) ranges from 70% to 91%. In other words, the PSA misses a significant number of cancers, and it also produces a fair number of false alarms.
False positives—elevated PSA levels without cancer—occur in about 1 in 4 men tested. Causes can include prostate infections, inflammation, or even recent sexual activity. False negatives also happen; a man can have a normal PSA and still harbor cancer.
The digital rectal exam doesn’t do much better. On its own, it detects about 50% to 60% of clinically significant cancers, depending on the study. When used together, PSA and DRE modestly improve detection, but even combined, the batting average isn’t stellar—roughly 60–70% accuracy overall.
That’s why these tests are viewed as screening tools, not diagnostics. Abnormal results typically lead to additional testing, such as MRI scans or prostate biopsies, to confirm a diagnosis.
Why Some Men Test Every Year
Because neither test is particularly reliable on its own, interval and trend matter. The most revealing information often comes not from one PSA number, but from how that number changes over time. A sharp year-to-year rise—even within the “normal” range—can be an early warning.
That’s why some men (and doctors) opt for annual PSA tests, even though the guidelines say every two to three years. The logic is simple: more data points mean better odds of catching a change early.
As one of our readers learned, that decision can mean everything.
🍁 Make a One-Time Contribution — Stand Up for Accountability in Vermont 🍁
He went in for his usual yearly checkup—just another visit for cholesterol, blood sugar, and the routine labs. As he was getting ready to leave, his doctor paused and said, “You’re not due for it, but let’s do a PSA this year anyway.”
That offhand decision changed his life.
The next morning, the doctor called. His PSA level was dangerously high. After further tests, he was diagnosed with stage 4 prostate cancer.
He’s now undergoing treatment, responding well, and credits that “extra” test—and a doctor’s instinct—for catching the disease before it got worse.
Symptoms: Often, There Aren’t Any
Prostate cancer can be a silent passenger. Many men never feel a thing until it’s advanced. When symptoms do appear, they may include:
- Difficulty starting or stopping urination
- Weak or interrupted urine flow
- Frequent urination, especially at night
- Pain or burning during urination or ejaculation
- Blood in urine or semen
- Pain in the lower back, hips, or pelvis
But it’s just as common to have no symptoms at all—which makes routine screening, however imperfect, vital.
Treatment and Outlook
When detected early, prostate cancer is one of the most treatable malignancies. Options include active surveillance, surgery, radiation therapy, hormone therapy, or newer targeted drugs for more advanced disease.
Even in metastatic cases, modern therapies have extended survival and improved quality of life significantly compared to a generation ago.
The Takeaway
Prostate cancer doesn’t have to kill you.
The tests aren’t perfect—in fact, they’re statistically mediocre. But they’re what we have, and used consistently, they save lives.
For men over 45, or those with family risk, the conversation with your doctor shouldn’t be if you’ll test, but how often. The official recommendation may be every two or three years, but some of us choose to do it annually—not because the test is flawless, but because repetition helps stack the odds in our favor.
When it comes to prostate cancer, catching it early isn’t luck. It’s a habit.
Dave Soulia | FYIVT
You can find FYIVT on YouTube | X(Twitter) | Facebook | Parler (@fyivt) | Gab | Instagram
#fyivt #ProstateCancerAwareness #MensHealth #EarlyDetection
Support Us for as Little as $5 – Get In The Fight!!
Make a Big Impact with $25/month—Become a Premium Supporter!
Join the Top Tier of Supporters with $50/month—Become a SUPER Supporter!
Subscribe to RSS
Leave a Reply